What is Bit Bio?
Bit Bio is a synthetic biology company focused on providing human cells for critical applications in research, drug discovery, and cell therapy. Leveraging a patented opti-ox safe harbour gene-targeting system, the company specializes in reprogramming human induced pluripotent stem cells (iPSCs) into highly defined and mature cell types. This proprietary technology enables precise control over cellular differentiation, paving the way for more accurate disease modeling and the development of novel therapeutic strategies.
How much funding has Bit Bio raised?
Bit Bio has raised a total of $255M across 6 funding rounds:
Angel/Seed
$471K
Series A
$41.5M
Series B
$103M
Other Financing Round
$30M
Private Equity
$30M
Series C
$50M
Angel/Seed (2017): $471K with participation from Jonathan Milner
Series A (2020): $41.5M led by Richard Klausner, Arch Venture Partners, Blueyard Capital, and Foresite Capital
Series B (2021): $103M supported by Arch Ventures, Foresite Capital, National Resilience, and Charles River Laboratories
Other Financing Round (2024): $30M featuring ARCH Venture Partners, M&G Investments, and Tencent
Private Equity (2024): $30M backed by M&G, BlueYard Capital, ARCH Venture Partners, and Puhua Capital
Series C (2026): $50M with participation from M&G
Key Investors in Bit Bio
ARCH Venture Partners
ARCH Venture Partners is a leading earlystage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
M&G Investments
M&G Investments is a company that operates in the Venture Capital & Private Equity industry. It employs 250to499 people and has 50Mto100M of revenue. The company is headquartered in Switzerland.
Tencent
Tencent Holdings Limited provides internet and mobile services, and online advertising services internationally. The company offers online and mobile games, applications across various internet and mobile platforms, instant messaging services, online literature services, wireless internet value added services, and interactive entertainment services. Tencent Holdings Limited was founded in 1998 and is headquartered in Shenzhen, China.
What's next for Bit Bio?
The substantial enterprise-level funding and recent strategic investment position Bit Bio for accelerated growth and market expansion. With a clear trajectory from its early-stage financing through Series B and beyond, the company is poised to scale its operations, further develop its proprietary cell programming platform, and advance its pipeline of differentiated cell products. This capital infusion is expected to fuel innovation, enhance manufacturing capabilities, and solidify Bit Bio's leadership in the rapidly evolving synthetic biology landscape, potentially driving significant advancements in regenerative medicine and personalized therapeutics.
See full Bit Bio company page
